142 related articles for article (PubMed ID: 15891184)
1. MR imaging of salivary duct carcinoma.
Motoori K; Iida Y; Nagai Y; Yamamoto S; Ueda T; Funatsu H; Ito H; Yoshitaka O
AJNR Am J Neuroradiol; 2005 May; 26(5):1201-6. PubMed ID: 15891184
[TBL] [Abstract][Full Text] [Related]
2. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?
Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Nakashima T; Oda Y; Honda H
Radiology; 2008 Dec; 249(3):909-16. PubMed ID: 18941162
[TBL] [Abstract][Full Text] [Related]
3. Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation.
Ikeda M; Motoori K; Hanazawa T; Nagai Y; Yamamoto S; Ueda T; Funatsu H; Ito H
AJNR Am J Neuroradiol; 2004 Aug; 25(7):1256-62. PubMed ID: 15313720
[TBL] [Abstract][Full Text] [Related]
4. Inter- and intratumoral variability in magnetic resonance imaging of pleomorphic adenoma: an attempt to interpret the variable magnetic resonance findings.
Motoori K; Yamamoto S; Ueda T; Nakano K; Muto T; Nagai Y; Ikeda M; Funatsu H; Ito H
J Comput Assist Tomogr; 2004; 28(2):233-46. PubMed ID: 15091129
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Parotid Tumors With Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging.
Abdel Razek AA; Samir S; Ashmalla GA
J Comput Assist Tomogr; 2017 Jan; 41(1):131-136. PubMed ID: 27636248
[TBL] [Abstract][Full Text] [Related]
6. Dynamic Contrast-Enhanced MRI to Differentiate Parotid Neoplasms Using Golden-Angle Radial Sparse Parallel Imaging.
Mogen JL; Block KT; Bansal NK; Patrie JT; Mukherjee S; Zan E; Hagiwara M; Fatterpekar GM; Patel SH
AJNR Am J Neuroradiol; 2019 Jun; 40(6):1029-1036. PubMed ID: 31048300
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma ex pleomorphic adenoma of major salivary glands: CT and MR imaging findings.
Wang C; Yu Q; Li S; Sun J; Zhu L; Wang P
Dentomaxillofac Radiol; 2021 Oct; 50(7):20200485. PubMed ID: 34161740
[TBL] [Abstract][Full Text] [Related]
8. Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI.
Yabuuchi H; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Hino T; Murayama Y; Yasumatsu R; Yamamoto H
Eur Radiol; 2020 Dec; 30(12):6402-6412. PubMed ID: 32613285
[TBL] [Abstract][Full Text] [Related]
9. Interest of diffusion-weighted and gadolinium-enhanced dynamic MR sequences for the diagnosis of parotid gland tumors.
Lechner Goyault J; Riehm S; Neuville A; Gentine A; Veillon F
J Neuroradiol; 2011 May; 38(2):77-89. PubMed ID: 20542568
[TBL] [Abstract][Full Text] [Related]
10. Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients.
Weon YC; Park SW; Kim HJ; Jeong HS; Ko YH; Park IS; Kim ST; Baek CH; Son YI
Neuroradiology; 2012 Jun; 54(6):631-40. PubMed ID: 22307272
[TBL] [Abstract][Full Text] [Related]
11. Basal cell adenoma of the parotid gland; MR features and differentiation from pleomorphic adenoma.
Mukai H; Motoori K; Horikoshi T; Takishima H; Nagai Y; Okamoto Y; Uno T
Dentomaxillofac Radiol; 2016; 45(4):20150322. PubMed ID: 26837669
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma ex pleomorphic adenoma of the parotid gland.
Kashiwagi N; Murakami T; Chikugo T; Tomita Y; Kawano K; Nakanishi K; Mori K; Tomiyama N
Acta Radiol; 2012 Apr; 53(3):303-6. PubMed ID: 22287150
[TBL] [Abstract][Full Text] [Related]
13. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland tumors of the parotid gland: CT and MR imaging findings with emphasis on intratumoral cystic components.
Kato H; Kanematsu M; Watanabe H; Mizuta K; Aoki M
Neuroradiology; 2014 Sep; 56(9):789-95. PubMed ID: 24948426
[TBL] [Abstract][Full Text] [Related]
15. The role of diffusion-weighted and dynamic contrast enhancement perfusion-weighted imaging in the evaluation of salivary glands neoplasms.
Pietragalla M; Nardi C; Bonasera L; Mungai F; Taverna C; Novelli L; De Renzis AGD; Calistri L; Tomei M; Occhipinti M; Colagrande S
Radiol Med; 2020 Sep; 125(9):851-863. PubMed ID: 32266692
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors.
Zheng N; Li R; Liu W; Shao S; Jiang S
Br J Radiol; 2018 Sep; 91(1089):20170707. PubMed ID: 29902075
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.
Yabuuchi H; Fukuya T; Tajima T; Hachitanda Y; Tomita K; Koga M
Radiology; 2003 Feb; 226(2):345-54. PubMed ID: 12563124
[TBL] [Abstract][Full Text] [Related]
18. Salivary duct carcinoma of the parotid gland: clinical and MR features in six patients.
Kashiwagi N; Takashima S; Tomita Y; Araki Y; Yoshino K; Taniguchi S; Nakanishi K
Br J Radiol; 2009 Oct; 82(982):800-4. PubMed ID: 19332520
[TBL] [Abstract][Full Text] [Related]
19. Salivary duct carcinoma.
Delgado R; Vuitch F; Albores-Saavedra J
Cancer; 1993 Sep; 72(5):1503-12. PubMed ID: 7688652
[TBL] [Abstract][Full Text] [Related]
20. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
